The Advocate Releases First Annual List of ‘Top Pharmaceutical Patient Advocacy Teams’

The Advocate: Supporting the Patient Voice, who provides bench-marking data to the pharma industry, has revealed its first ever list of top overall pharmaceutical patient advocacy organizations. The program’s goal is to keep the patient at the center of all healthcare decision making by elevating the voice of patient advocacy organizations (PAOs).

The ranking of that list was completed by assigning point values for placing within the top five for each of the five stack-ranked categories. The Advocate then pooled the total points earned by each organization to generate the overall scores shown in the graph below.

The Advocate's top pharmaceutical patient advocacy organizations for 2021/2022

In first place with a cumulative score of 23 out of a total 25 points is Janssen, The Pharmaceutical Companies of Johnson & Johnson, followed by Bristol Myers Squibb (BMS) with 16 overall points, and Pfizer rounding out the top three.

“We acclaim our top three overall pharmaceutical advocacy teams and commend runners up: Amgen in fourth overall with 11 points, Eli Lilly in fourth with seven points, Merck in sixth with five points, and AstraZeneca, Sanofi, and AbbVie rounding out the ranks with one point each,” notes Matt Toresco, editor-in-chief of the syndicated market research program. “This was a great year for all organizations involved, and we look forward to bringing forth this metric in future years."